Press Release

SkinPen® Precision Now Under Direct Management in the United Kingdom and Ireland

April 12, 2021 (Dallas). Crown Aesthetics, a division of Crown Laboratories, Inc., is delighted to announce that SkinPen Precision, the first microneedling device cleared by the FDA and the gold standard for skin remodeling technology, now has a direct presence in the UK and Ireland.

The market arrival of Crown Aesthetics (formerly known as Bellus Medical) is a significant organizational investment that confirms Crown’s commitment to its customers and patients. Well-known for its dedication to excellence, Crown’s investment ensures a best-in-class level of service that SkinPen Precision customers and patients have come to expect across the globe.

“By directly supporting our SkinPen customers, we will help them grow their practices by driving patient demand,” said Andy Moulton, Vice President of Sales, International for Crown Aesthetics. “They will now receive the superior level of training, education, and customer service they deserve.”

Launched in 2013 and backed by over 90 validation studies*, SkinPen Precision is a superior US engineered and manufactured skin remodeling device. SkinPen’s CE intended use includes treatment to improve the appearance of facial acne scars in adults aged 22 years or older and to improve the appearance of fine lines and wrinkles on the face and neck. SkinPen also treats pigmentation conditions (Dyschromia) including Melasma, Vitiligo, and Solar Lentigines (sun/age spots). SkinPen Precision is a Class IIa medical device that works by creating controlled micro-injuries to stimulate the body’s natural wound-healing response and remodel scar tissue. The award-winning SkinPen has a superior safety profile and is clinically proven effective on all Fitzpatrick skin types. Patients experience minimal cellular damage and little to no downtime.



Opening Hours: Monday - Friday 9:00 am – 17:00 pm


Orders or Questions



Key Crown Aesthetics Contacts

Customer Service (Ballyclare, Northern Ireland)

Lisa Scott, Customer Success Specialist
UK: 028 9334 4411
Ireland: +44 28 9334 4411


Marketing / Communications

Reena Sandhu, Head of Aesthetics Marketing Operations, UK/Ireland,  07365 145 207

General Enquiry - 

Medical/Clinical - 


SkinPen Precision websites:


About Crown Aesthetics

Crown Aesthetics, the premier medical aesthetics company, is dedicated to helping leading aesthetic practices around the world grow their businesses. We do that by delivering dramatic results in rejuvenation and restoration. Our non-invasive innovations – SkinPen®, the first FDA-cleared microneedling device; the post-microneedling protocol Skinfuse®; and the platelet-rich plasma (PRP) system ProGenTM Advantage – act as "gateway" products that draw new consumers to practices. Based in Dallas, Texas, Crown Aesthetics sets industry standards for efficacy, safety, and innovation. As a result, our customers consistently deliver the best aesthetic care in the business. For more information, please visit



* Crown Aesthetics data on file.

For US indication, complete clinical trial summary, and important safety information including contraindication and how to use the SkinPen Precision microneedling device, visit


For media enquiries:

Black & White Comms
Sophie Woodward
Tel: +447973 767 592 /